Cargando…

Utilizing Publicly Available Cancer Clinicogenomic Data on CBioPortal to Compare Epidermal Growth Factor Receptor Mutant and Wildtype Non-Small Cell Lung Cancer

Publicly available clinicogenomic data on platforms such as the cancer BioPortal (cBioPortal.org) allow for efficient analyses by researchers with little or no experience working with Big Data. cBioPortal.org also allows for appropriate statistical testing and downloadable images for easy disseminat...

Descripción completa

Detalles Bibliográficos
Autor principal:	Dhar, Chirag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149776/ https://www.ncbi.nlm.nih.gov/pubmed/34055528 http://dx.doi.org/10.7759/cureus.14683

Ejemplares similares

GNOSIS: an R Shiny app supporting cancer genomics survival analysis with cBioPortal
por: King, Lydia, et al.
Publicado: (2022)

Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal
por: Buechner, Philipp, et al.
Publicado: (2020)

Searching of Clinical Trials Made Easier in cBioPortal Using Patients' Genetic and Clinical Profiles
por: Unberath, Philipp, et al.
Publicado: (2022)

Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal
por: de Bruijn, Ino, et al.
Publicado: (2023)

A patient-driven clinicogenomic partnership for metastatic prostate cancer
por: Crowdis, Jett, et al.
Publicado: (2022)

Clinicopathological characteristics, survival outcomes, and genetic alterations of younger patients with gastric cancer: Results from the China National Cancer Center and cBioPortal datasets
por: Niu, Penghui, et al.
Publicado: (2022)

Reducing inequities in maternal and child health in rural Guatemala through the CBIO+ Approach of Curamericas: 9. Key stakeholder perspectives on strengthening the CBIO+ Approach
por: Lambden, Jason, et al.
Publicado: (2023)

cbpManager: a web application to streamline the integration of clinical and genomic data in cBioPortal to support the Molecular Tumor Board
por: Ustjanzew, Arsenij, et al.
Publicado: (2021)

Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis
por: Dodoo, Grace N, et al.
Publicado: (2023)

Integrative cBioPortal Analysis Revealed Molecular Mechanisms That Regulate EGFR-PI3K-AKT-mTOR Pathway in Diffuse Gliomas of the Brain
por: Brlek, Petar, et al.
Publicado: (2021)

Analyzing the influence of IL18 in regulation of YAP1 in breast oncogenesis using cBioportal
por: Rahman, Ayesha, et al.
Publicado: (2021)

An Idealized Clinicogenomic Registry to Engage Underrepresented Populations Using Innovative Technology
por: Silva, Patrick, et al.
Publicado: (2022)

Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study
por: Kemps, Paul G., et al.
Publicado: (2022)

The rod synapse in aging wildtype and Dscaml1 mutant mice
por: Clemons, Mellisa R., et al.
Publicado: (2023)

Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women
por: Tabbal, Marah, et al.
Publicado: (2023)

Clinicogenomic Characteristics and Treatment of Young-Onset Colorectal Cancer Patients Treated With Palliative Therapy in Real-World Practice
por: Jeong, Hyehyun, et al.
Publicado: (2022)

Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer
por: Hong, Lingzhi, et al.
Publicado: (2023)

Maximizing the utility of public data
por: Ahmed, Mahmoud, et al.
Publicado: (2023)

Interactions Between Wildtype and Mutant Ras Genes in Lung and Skin Carcinogenesis
por: To, Minh D., et al.
Publicado: (2012)

The capsaicin binding affinity of wildtype and mutant TRPV1 ion channels
por: Li, Shisheng, et al.
Publicado: (2023)

Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer
por: Mayayo-Peralta, Isabel, et al.
Publicado: (2021)

The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia
por: O'Connor, David, et al.
Publicado: (2023)

Multiple Cases of Bacterial Sequence Erroneously Incorporated Into Publicly Available Chloroplast Genomes
por: Robinson, Aaron J., et al.
Publicado: (2022)

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
por: Diplas, Bill H., et al.
Publicado: (2018)

Reducing inequities in maternal and child health in rural Guatemala through the CBIO+ Approach of Curamericas: 5. Mortality assessment
por: Perry, Henry B., et al.
Publicado: (2023)

Expression of CD133 Cancer Stem Cell Marker in IDH-Mutant and IDH-wildtype (Isocitrate Dehydrogenase) Astrocytoma
por: Sabunga, Olivia Desty, et al.
Publicado: (2022)

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium
por: Hässler, Signe, et al.
Publicado: (2020)

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer
por: Sjöström, Martin, et al.
Publicado: (2019)

Wildtype epidermal growth factor receptor (Egfr) is not required for daily locomotor or masking behavior in mice
por: Roberts, Reade B, et al.
Publicado: (2006)

Effectively utilizing publicly available databases for cancer target evaluation
por: Croft, Daniel, et al.
Publicado: (2023)

Reducing inequities in maternal and child health in rural Guatemala through the CBIO+ Approach of Curamericas: 8. Impact on women’s empowerment
por: Stollak, Ira, et al.
Publicado: (2023)

Reducing inequities in maternal and child health in rural Guatemala through the CBIO+ Approach of Curamericas: 1. Introduction and project description
por: Valdez, Mario, et al.
Publicado: (2023)

Epidermal Growth Factor Receptor-mutated Lung Cancer as the Initial Manifestation of Germline TP53 Mutation Associated Cancer
por: Pathak, Surabhi, et al.
Publicado: (2018)

A Pan-Cancer Study of Epidermal Growth Factor-Like Domains 6/7/8 as Therapeutic Targets in Cancer
por: Shi, Shanping, et al.
Publicado: (2020)

S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas
por: Mehdi, A., et al.
Publicado: (2023)

Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures
por: Nielsen, Søren Bang, et al.
Publicado: (2013)

Clinicogenomic factors and treatment patterns among patients with advanced non–small cell lung cancer with or without brain metastases in the United States
por: Smyth, Emily Nash, et al.
Publicado: (2023)

Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study
por: Safi, Mohammed, et al.
Publicado: (2022)

Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC-50 Model
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia
por: Romine, Kyle A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p332pbc6kn70qsbgdc12csm1tp